Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.
D000450:Aldosterone / Q000096:biosynthesis / Q000097:blood; D002073:Butanes / Q000494:pharmacology; D003864:Depression, Chemical; D004231:Diuresis / Q000187:drug effects; D006400:Hematocrit; D006801:Humans; D006852:Hydrochlorothiazide / Q000032:analysis*; D006929:Hyperaldosteronism / Q000139:chemically induced* / Q000378:metabolism / Q000652:urine; D007664:Ketosteroids / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000652:urine; D011245:Pregnadienes / Q000494:pharmacology*; D012964:Sodium / Q000652:urine; D013148:Spironolactone / Q000378:metabolism; D013997:Time Factors
D002073:Butanes; D007664:Ketosteroids; D007783:Lactones; D000451:Mineralocorticoid Receptor Antagonists; D011245:Pregnadienes; D006852:Hydrochlorothiazide; D013148:Spironolactone; D000450:Aldosterone; D012964:Sodium; D011188:Potassium